$GALT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GALECTIN THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GALECTIN THERAPEUTICS INC. Get notifications about new insider transactions in GALECTIN THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.84 | 10,000 | 38,400 | 6,288,940 | 6.3 M to 6.3 M (-0.16 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 4.47 | 7,500 | 33,525 | 6,298,940 | 6.3 M to 6.3 M (-0.12 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.95 | 5,000 | 19,750 | 6,306,440 | 6.3 M to 6.3 M (-0.08 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.52 | 5,000 | 17,600 | 6,311,440 | 6.3 M to 6.3 M (-0.08 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.84 | 10,000 | 38,400 | 6,288,940 | 6.3 M to 6.3 M (-0.16 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 4.47 | 7,500 | 33,525 | 6,298,940 | 6.3 M to 6.3 M (-0.12 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.95 | 5,000 | 19,750 | 6,306,440 | 6.3 M to 6.3 M (-0.08 %) |
May 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.52 | 5,000 | 17,600 | 6,311,440 | 6.3 M to 6.3 M (-0.08 %) |
May 03 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 4.42 | 3,771 | 16,668 | 213,249 | 209.5 K to 213.2 K (+1.80 %) |
Apr 19 2021 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 5.00 | 2,000,000 | 10,000,000 | 10,000,000 | |
Apr 16 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.23 | 7,474 | 16,667 | 209,478 | 202 K to 209.5 K (+3.70 %) |
Apr 06 2021 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 2.04 | 5,000 | 10,200 | 30,000 | 25 K to 30 K (+20.00 %) |
Mar 31 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.17 | 7,680 | 16,666 | 202,004 | 194.3 K to 202 K (+3.95 %) |
Mar 31 2021 | GALT | GALECTIN THERAPEUT ... | Schwartz Elissa J. | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 31 2021 | GALT | GALECTIN THERAPEUT ... | Schwartz Elissa J. | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 31 2021 | GALT | GALECTIN THERAPEUT ... | Zordani Richard A. Jr. | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 31 2021 | GALT | GALECTIN THERAPEUT ... | Zordani Richard A. Jr. | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 2.11 | 100,000 | 211,000 | 100,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | See Remarks | Option Exercise | A | 2.11 | 140,000 | 295,400 | 140,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | See Remarks | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 2.11 | 100,000 | 211,000 | 100,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
Mar 08 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.22 | 27,027 | 60,000 | 214,684 | 187.7 K to 214.7 K (+14.40 %) |
Mar 04 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.31 | 10,000 | 23,100 | 6,326,440 | 6.3 M to 6.3 M (-0.16 %) |
Mar 01 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.24 | 7,440 | 16,666 | 187,657 | 180.2 K to 187.7 K (+4.13 %) |
Feb 16 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.49 | 6,693 | 16,666 | 180,217 | 173.5 K to 180.2 K (+3.86 %) |
Feb 05 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.04 | 10,000 | 20,400 | 6,336,440 | 6.3 M to 6.3 M (-0.16 %) |
Jan 19 2021 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Sell | S | 2.17 | 60,000 | 130,200 | 60,614 | 120.6 K to 60.6 K (-49.75 %) |
Jan 19 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.19 | 7,610 | 16,666 | 165,021 | 157.4 K to 165 K (+4.83 %) |
Jan 05 2021 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.23 | 10,000 | 22,300 | 6,346,440 | 6.4 M to 6.3 M (-0.16 %) |
Jan 05 2021 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.24 | 7,440 | 16,666 | 157,411 | 150 K to 157.4 K (+4.96 %) |
Dec 16 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.52 | 6,614 | 16,667 | 149,971 | 143.4 K to 150 K (+4.61 %) |
Oct 19 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.87 | 5,807 | 16,666 | 124,324 | 118.5 K to 124.3 K (+4.90 %) |
Oct 15 2020 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.97 | 10,000 | 29,700 | 6,356,440 | 6.4 M to 6.4 M (-0.16 %) |
Sep 17 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | President and CEO | Grant | A | 2.93 | 5,171 | 15,151 | 112,275 | 107.1 K to 112.3 K (+4.83 %) |
Sep 09 2020 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 2.57 | 5,000 | 12,848 | 25,000 | 20 K to 25 K (+25.00 %) |
Sep 09 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 2.55 | 10,000 | 25,500 | 7,893,191 | 7.9 M to 7.9 M (+0.13 %) |
Sep 02 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Chief Executive Off ... | Option Exercise | A | 2.65 | 250,000 | 662,500 | 250,000 | |
Mar 20 2020 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 1.64 | 6,000 | 9,844 | 20,000 | 14 K to 20 K (+42.86 %) |
Mar 16 2020 | GALT | GALECTIN THERAPEUT ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 1.75 | 300,000 | 525,000 | 300,000 | |
Feb 14 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | M | 4.72 | 18,638 | 87,971 | 21,362 | |
Feb 14 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | M | 2.39 | 46,875 | 112,031 | 0 | |
Feb 14 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | M | 4.72 | 18,638 | 87,971 | 7,883,191 | 7.9 M to 7.9 M (+0.24 %) |
Feb 14 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | M | 2.39 | 46,875 | 112,031 | 7,864,553 | 7.8 M to 7.9 M (+0.60 %) |
Feb 10 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Option Exercise | M | 2.39 | 8,000 | 19,120 | 54,250 | |
Feb 10 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | M | 2.39 | 8,000 | 19,120 | 107,104 | 99.1 K to 107.1 K (+8.07 %) |
Jan 21 2020 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.97 | 10,000 | 29,700 | 6,375,790 | 6.4 M to 6.4 M (-0.16 %) |
Jan 21 2020 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 2.97 | 10,000 | 29,700 | 6,375,790 | 6.4 M to 6.4 M (-0.16 %) |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 2.86 | 45,000 | 128,700 | 45,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Grant | A | 2.86 | 12,238 | 35,001 | 7,817,678 | 7.8 M to 7.8 M (+0.16 %) |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Option Exercise | A | 2.86 | 40,000 | 114,400 | 40,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Grant | A | 2.86 | 20,455 | 58,501 | 99,104 | 78.6 K to 99.1 K (+26.01 %) |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | A | 2.86 | 30,000 | 85,800 | 30,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 2.86 | 40,000 | 114,400 | 40,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 2.86 | 45,000 | 128,700 | 45,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Option Exercise | A | 2.86 | 30,000 | 85,800 | 30,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.86 | 30,000 | 85,800 | 30,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 2.86 | 50,000 | 143,000 | 50,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Executive Off ... | Option Exercise | A | 2.86 | 70,000 | 200,200 | 70,000 | |
Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | A | 2.86 | 40,000 | 114,400 | 40,000 | |
Nov 18 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 3.36 | 3,000 | 10,076 | 14,000 | 11 K to 14 K (+27.27 %) |
Oct 15 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 3.73 | 17,000 | 63,325 | 6,385,790 | 6.4 M to 6.4 M (-0.27 %) |
Oct 15 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | J | 0.00 | 38,690 | 0 | 6,402,790 | 6.4 M to 6.4 M (-0.60 %) |
Sep 09 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Buy | S | 3.30 | 30,000 | 99,000 | 124,614 | 94.6 K to 124.6 K (+31.71 %) |
Sep 09 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 3.71 | 1,290 | 4,786 | 11,000 | 9.7 K to 11 K (+13.29 %) |
Jul 25 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | J | 0.00 | 306 | 0 | 6,441,480 | 6.4 M to 6.4 M (0.00 %) |
Jun 12 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | J | 0.00 | 67,515 | 0 | 6,441,786 | 6.5 M to 6.4 M (-1.04 %) |
Jun 05 2019 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Executive Off ... | Option Exercise | M | 1.37 | 8,706 | 11,927 | 29,294 | |
Jun 05 2019 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Executive Off ... | Buy | M | 1.37 | 8,706 | 11,927 | 8,706 | 0 to 8.7 K |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | P | 7.00 | 7,847 | 54,929 | 7,847 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | P | 4.28 | 2,354 | 10,075 | 3,614 | 1.3 K to 3.6 K (+186.83 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | P | 7.00 | 10,110 | 70,770 | 10,110 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Buy | P | 4.28 | 3,033 | 12,981 | 44,415 | 41.4 K to 44.4 K (+7.33 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | P | 7.00 | 25,700 | 179,900 | 25,700 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | P | 7.00 | 4,753 | 33,271 | 4,753 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.28 | 1,426 | 6,103 | 23,469 | 22 K to 23.5 K (+6.47 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.28 | 7,710 | 32,999 | 9,710 | 2 K to 9.7 K (+385.50 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | P | 7.00 | 61,929 | 433,503 | 61,929 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Buy | P | 4.28 | 18,578 | 79,514 | 66,769 | 48.2 K to 66.8 K (+38.55 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Option Exercise | P | 7.00 | 42,831 | 299,817 | 42,831 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | P | 4.28 | 12,849 | 54,994 | 78,649 | 65.8 K to 78.6 K (+19.53 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | P | 7.00 | 25,700 | 179,900 | 25,700 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | P | 7.00 | 15,576,322 | 109,034,254 | 15,576,322 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | M | 5.00 | 500,000 | 2,500,000 | 966,204 | |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.28 | 7,710 | 32,999 | 27,710 | 20 K to 27.7 K (+38.55 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.28 | 4,672,896 | 19,999,995 | 7,801,385 | 3.1 M to 7.8 M (+149.37 %) |
Jun 03 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | M | 5.00 | 500,000 | 2,500,000 | 3,128,489 | 2.6 M to 3.1 M (+19.02 %) |
Apr 09 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.82 | 20,700 | 99,851 | 2,628,489 | 2.6 M to 2.6 M (+0.79 %) |
Apr 08 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | P | 4.82 | 667 | 3,214 | 65,800 | 65.1 K to 65.8 K (+1.02 %) |
Apr 08 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.81 | 21,000 | 100,972 | 2,607,789 | 2.6 M to 2.6 M (+0.81 %) |
Apr 08 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.73 | 500 | 2,365 | 2,000 | 1.5 K to 2 K (+33.33 %) |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 1.12 | 1,008,000 | 1,132,790 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 1.49 | 1,125,000 | 1,680,525 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 2.69 | 375,000 | 1,010,175 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 285,000 | 855,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 155,000 | 465,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 167,500 | 502,500 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 162,500 | 487,500 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 162,500 | 487,500 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 155,000 | 465,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 162,500 | 487,500 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 150,000 | 450,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 250,000 | 750,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 450,000 | 1,350,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | C | 3.00 | 900,000 | 2,700,000 | 0 | |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | C | 1.12 | 896,997 | 1,008,045 | 6,509,301 | 5.6 M to 6.5 M (+15.98 %) |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | C | 1.49 | 753,138 | 1,125,038 | 5,612,304 | 4.9 M to 5.6 M (+15.50 %) |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | C | 2.69 | 139,211 | 375,007 | 4,859,166 | 4.7 M to 4.9 M (+2.95 %) |
Apr 01 2019 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | C | 3.00 | 2,000,000 | 6,000,000 | 4,719,955 | 2.7 M to 4.7 M (+73.53 %) |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 2.39 | 859 | 2,053 | 33,065 | |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 2.39 | 43,326 | 103,549 | 33,924 | |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.02 | 859 | 5,175 | 13,581 | 14.4 K to 13.6 K (-5.95 %) |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 2.39 | 859 | 2,053 | 14,440 | 13.6 K to 14.4 K (+6.33 %) |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.02 | 43,326 | 261,026 | 13,581 | 56.9 K to 13.6 K (-76.13 %) |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 2.39 | 43,326 | 103,549 | 56,907 | 13.6 K to 56.9 K (+319.02 %) |
Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.00 | 7,000 | 42,000 | 13,581 | 20.6 K to 13.6 K (-34.01 %) |
Feb 11 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | P | 4.48 | 1,000 | 4,484 | 65,133 | 64.1 K to 65.1 K (+1.56 %) |
Feb 11 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.29 | 1,500 | 6,428 | 1,500 | 0 to 1.5 K |
Feb 04 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Sell | S | 5.00 | 13,047 | 65,235 | 154,614 | 167.7 K to 154.6 K (-7.78 %) |
Feb 04 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Sell | S | 5.00 | 16,953 | 84,765 | 167,661 | 184.6 K to 167.7 K (-9.18 %) |
Jan 30 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | P | 4.81 | 1,000 | 4,805 | 64,133 | 63.1 K to 64.1 K (+1.58 %) |
Jan 30 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.87 | 48,500 | 236,244 | 2,586,789 | 2.5 M to 2.6 M (+1.91 %) |
Jan 30 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Buy | P | 4.77 | 3,000 | 14,315 | 2,538,289 | 2.5 M to 2.5 M (+0.12 %) |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | M | 2.39 | 62,250 | 148,778 | 0 | |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | M | 0.89 | 41,500 | 36,935 | 0 | |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Payment of Exercise | F | 4.75 | 31,322 | 148,780 | 184,614 | 215.9 K to 184.6 K (-14.51 %) |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Buy | M | 2.39 | 62,250 | 148,778 | 215,935 | 153.7 K to 215.9 K (+40.50 %) |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Payment of Exercise | F | 4.75 | 7,776 | 36,936 | 153,685 | 161.5 K to 153.7 K (-4.82 %) |
Jan 23 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Buy | M | 0.89 | 41,500 | 36,935 | 161,461 | 120 K to 161.5 K (+34.59 %) |
Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 4.72 | 40,000 | 188,800 | 40,000 | |
Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Grant | A | 4.72 | 7,415 | 34,999 | 2,535,289 | 2.5 M to 2.5 M (+0.29 %) |
Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Option Exercise | A | 4.72 | 35,000 | 165,200 | 35,000 | |
Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Grant | A | 4.72 | 11,653 | 55,002 | 63,133 | 51.5 K to 63.1 K (+22.64 %) |